Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis

Journal of Comparative Neurology

Volumn 430, Issue 1, 2001, Pages 131-144

  Sakai, Yuko ^a   Hira, Yoshiki ^a   Matsushima, Shoji ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Antibody; Experimental autoimmune encephalomyelitis; Extravasation; Multiple sclerosis; Pathogenesis

Indexed keywords

IMMUNOGLOBULIN G;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; LEUKOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; CEREBELLUM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LUMBAR VERTEBRAE; MICE; PARALYSIS; RABBITS; SPINAL CORD; THORACIC VERTEBRAE; TIME FACTORS;

EID: 0035966659     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20010129)430:1<131::AID-CNE1019>3.0.CO;2-K     Document Type: Article

References (38)

1. Immunocytochemical localization of immunoglobulins in the rat brain: Relationship to the blood-brain barrier
2. Comparison between multiple sclerosis in India and the United States: A case-control study
3. A study of abnormal blood-brain permeability in experimental allergic encephalomyelitis
4. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis
5. Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice
6. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: Implications for the study of multiple sclerosis
7. 125 gamma globulin and leukocytes in allergic encephalomyelitis
8. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis
9. Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting
10. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
11. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
12. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption
13. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein
14. Changes in the clinical phenotype of multiple sclerosis during the past 50 years in Japan
15. Chronic relapsing experimental allergic encephalomyelitis: Studies in vascular permeability changes
16. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis
17. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
18. Measurement of cell-mediated inflammation in experimental murine autoimmune encephalomyelitis by radioisotopic labeling
19. Acute experimental autoimmune encephalomyelitis in mice: Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system
20. Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis
21. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis
22. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis
23. Blood-brain barrier and DNA changes during the evolution of experimental allergic encephalomyelitis
24. Immunohistochemical study of allergic encephalomyelitis
25. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies
26. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease
27. Differential permeability of the BBB in acute EAE: Enhanced transport of TNF-alpha
28. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A
29. Mononuclear cell accumulation and plasma protein extravasation (PPE) during induction, remission and re-challenge of experimental allergic encephalomyelitis in the rat
30. Experimental autoimmune encephalomyelitis: An anatomically-based explanation of clinical progression in rodents
31. Simultaneous visualization of vascular permeability change and leukocyte egress in the central nervous system during autoimmune encephalomyelitis
32. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimegluine-enhancing magnetic resonance imaging lesions
33. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender, and age
34. Autoimmune demyelination in the central nervous system
35. Rabbit IgG distribution in skin, spinal cord and DRG following systemic injection in rat
36. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
37. Immunoglobulin molecules are present in early-generated neuronal populations in the rat cerebral cortex and retina
38. Permeability of cerebral blood vessels in experimental allergic encephalomyelitis studied by radioactive iodinated bovine albumin